🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Pulmonary Hypertension Due to Lung Diseases

Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension. NCT07537517n/a1 site📍 Madrid Hospital General Universitario Gregorio Marañon Bioenergetic Effect of Pioglitazone in CLD-PH NCT06336798Phase 21 site📍 Atlanta Emory University · Tests: Pioglitazone 30mg, Placebo, Labs Giessen Pulmonary Hypertension in Lung Cancer Registry NCT04467333n/a1 site📍 Giessen University of Giessen · Tests: All lung cancer patients. HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction NCT07123779Phase 1, Phase 23 sites📍 Kansas City📍 Greenville📍 Dallas 35Pharma Inc., a GSK company · Tests: HS235, Placebo Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) NCT07322133Phase 41 site📍 Sacramento University of California, Davis · Tests: Dopamine administration, Norepinephrine Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases NCT07777367NA1 site📍 Zurich Silvia Ulrich Somaini · Tests: 6-minute walk distance (6MWD) test on ambient conditions, 6-minute walk distance (6MWD) test with supplemental oxygen (… Ventilator Pressure and Optimization of Compliance and Hemodynamics NCT06512935NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: Increase in the PEEP followed by decrease in the PEEP, Decrease in the PEEP followed by increase in the PEEP A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease NCT07214376NA18 sites📍 Tucson📍 New Haven📍 Weston Pulnovo Medical, Inc. · Tests: Pulmonary Artery Denervation (PADN), Sham procedure control Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure NCT06299436n/a1 site📍 Baltimore Johns Hopkins University Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD) NCT07777445NA1 site📍 Zurich Silvia Ulrich Somaini · Tests: 6-minute walk distance (6MWD) test on ambient conditions, 6-minute walk distance (6MWD) test with supplemental oxygen (… DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT06388421n/a71 sites📍 Birmingham📍 Phoenix📍 Los Angeles United Therapeutics · Tests: Prospective study assessments Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease NCT07473700Phase 216 sites📍 Phoenix📍 San Francisco📍 Boise Tectonic Operating Company, Inc. · Tests: TX000045 Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients NCT07498244n/a1 site📍 Graz Medical University of Graz A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD NCT07285655Phase 344 sites📍 Phoenix📍 Scottsdale📍 Los Angeles Liquidia Technologies, Inc. · Tests: L606, Placebo LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT05798923Phase 24 sites📍 Tucson📍 New Haven📍 Boston IRulya Therapeutics Inc. · Tests: Placebo, LAM-001 Pulmonary Hypertension Biorepository and Registry NCT04808596n/a1 site📍 Kansas City University of Kansas Medical Center Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease NCT05844462Phase 31 site📍 Le Kremlin-Bicêtre Assistance Publique - Hôpitaux de Paris · Tests: Tadalafil, Placebo Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension NCT04484675Phase 41 site📍 Zagazig Zagazig University · Tests: Milrinone inhalation, Milrinone infusion
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy